Kulkarni, S., Bill, A., Godse, N. R., Khan, N. I., Kass, J. I., Steehler, K., . . . Duvvuri, U. (2017). TMEM16A/ANO1 Suppression Improves Response to Antibody Mediated Targeted Therapy of EGFR and HER2/ERBB2. Genes Chromosomes Cancer.
Chicago ZitierstilKulkarni, Sucheta, et al. "TMEM16A/ANO1 Suppression Improves Response to Antibody Mediated Targeted Therapy of EGFR and HER2/ERBB2." Genes Chromosomes Cancer 2017.
MLA ZitierstilKulkarni, Sucheta, et al. "TMEM16A/ANO1 Suppression Improves Response to Antibody Mediated Targeted Therapy of EGFR and HER2/ERBB2." Genes Chromosomes Cancer 2017.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.